NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 428.00K | 135.00K | 0.00 | 0.00 | 0.00 | |||
Cost Of Goods | N/A | 0.00 | N/A | N/A | N/A | |||
Gross Profit | N/A | 135.00K | N/A | N/A | N/A | |||
Operating Expenses | 18.14M | 17.98M | 14.21M | 11.61M | 4.45M | |||
Research and Development | 9.84M | 9.11M | 5.97M | 2.82M | 2.77M | |||
Selling, General, and Administrative Expenses | 8.30M | 8.87M | 8.24M | 6.60M | 1.68M | |||
Operating Income | -17.71M | -17.84M | -14.21M | -11.61M | -4.45M | |||
Interest Income/Expense | 2.20M | -840.00K | -536.00K | -1.23M | -240.00K | |||
Other Income/Expense | -387.00K | -6.14M | -6.54M | -10.17M | 90.00K | |||
Non Recurring Items | N/A | 0.00 | -4.95M | N/A | 0.00 | |||
Income Before Taxes | -15.90M | -24.83M | -26.23M | -23.01M | -4.60M | |||
Income Tax | 6.00K | 3.00K | 0.00 | 0.00 | 0.00 | |||
Net Income | -15.90M | -24.83M | -26.23M | -23.01M | -4.60M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -3.46 | -6.63 | -30.26 | -1.81 | -0.36 | |||
Non GAAP EPS | -3.47 | -7.78 | N/A | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | N/A | 100.00% | N/A | N/A | N/A | |||
Profit Margin | -3716.12% | -18392.59% | N/A | N/A | N/A | |||
Operating Profit Margin | -4138.79% | -13216.30% | N/A | N/A | N/A |
All data in USD